FDA approves pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare haematologic malignancy
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
FDA approves pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare haematologic malignancy
CHMP issues positive opinion for encorafenib in combination with cetuximab and FOLFOX for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer
‘Intelligent tattoo' detects skin cancer before it appears
Blood test detects early signs of breast cancer recurrence
Targeted platinum-antibody conjugates boost tumour visibility to the immune system
Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial
TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
Sacituzumab govitecan receives positive CHMP opinion in first-line metastatic triple-negative Breast cancer
Positive EU CHMP opinion for pembrolizumab in combination with enfortumab vedotin-ejfv as perioperative treatment in muscle-invasive bladder cancer
Cholesterol-craving cancers need lipid enzymes to use metabolites for growth